CPS Capital makes investment in nutrition CRO KGK Science

KGK Science Inc, a contract research organization (CRO) offering human clinical trials and regulatory services to the health nutrition industry, has secured an investment from CPS Capital, a Canadian private equity firm. No financial terms were disclosed. The partnership with CPS will help the London, Ontario-based company pursue strategic growth opportunities. Founded in 1997, KGK Science is led by President and CEO Najla Guthrie. Vancouver's CPS provides growth capital to small and medium-sized businesses in Canada, the United States, and other developed markets.

DealsCanadaNorth AmericaBriefs